2335 — Shaanxi Micot Pharmaceutical Technology Balance Sheet
0.000.00%
Last trade - 00:00- HK$7.96bn
- HK$6.58bn
Annual balance sheet for Shaanxi Micot Pharmaceutical Technology, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2024 December 31st | 2025 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | IFRS | IFRS |
| Status: | Final | Final |
| Cash and Equivalents | ||
| Short Term Investments | ||
| Cash and Short Term Investments | 180 | 236 |
| Net Total Receivables | 0.652 | 1.09 |
| Prepaid Expenses | ||
| Total Other Current Assets | ||
| Total Current Assets | 186 | 262 |
| Gross Property, Plant And Equipment | ||
| Accumulated Depreciation | ||
| Net Property, Plant And Equipment | 12.1 | 25.4 |
| Long Term Investments | ||
| Long Term Notes Receivable | ||
| Other Long Term Assets | ||
| Total Assets | 247 | 331 |
| Payable / Accrued | ||
| Accrued Expenses | ||
| Notes Payable / Short Term Debt | ||
| Current Portion of Long Term Debt / Capital Leases | ||
| Total Other Current Liabilities | ||
| Total Current Liabilities | 77.9 | 266 |
| Long Term Debt | ||
| Capital Lease Obligations | ||
| Total Long Term Debt | ||
| Total Debt | ||
| Minority Interest | ||
| Total Liabilities | 135 | 1,304 |
| Additional Paid In Capital | ||
| Retained Earnings (Accumulated Deficit) | ||
| ESOP Debt Guarantee | ||
| Other Equity | ||
| Total Equity | 112 | -972 |
| Total Liabilities & Shareholders' Equity | 247 | 331 |
| Total Common Shares Outstanding |